410 related articles for article (PubMed ID: 33150374)
21. High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse.
Velázquez-Avila M; Balandrán JC; Ramírez-Ramírez D; Velázquez-Avila M; Sandoval A; Felipe-López A; Nava P; Alvarado-Moreno JA; Dozal D; Prieto-Chávez JL; Schaks M; Rottner K; Dorantes-Acosta E; López-Martínez B; Schnoor M; Pelayo R
Leukemia; 2019 Jun; 33(6):1337-1348. PubMed ID: 30573781
[TBL] [Abstract][Full Text] [Related]
22. BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.
Roccaro AM; Sacco A; Maiso P; Azab AK; Tai YT; Reagan M; Azab F; Flores LM; Campigotto F; Weller E; Anderson KC; Scadden DT; Ghobrial IM
J Clin Invest; 2013 Apr; 123(4):1542-55. PubMed ID: 23454749
[TBL] [Abstract][Full Text] [Related]
23. The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signalling.
David A; Zocchi S; Talbot A; Choisy C; Ohnona A; Lion J; Cuccuini W; Soulier J; Arnulf B; Bories JC; Goodhardt M; Garrick D
Leukemia; 2021 Jun; 35(6):1710-1721. PubMed ID: 32879426
[TBL] [Abstract][Full Text] [Related]
24. Prediction and prognostic significance of BCAR3 expression in patients with multiple myeloma.
Zhang W; Lin Y; Liu X; He X; Zhang Y; Fu W; Yang Z; Yang P; Wang J; Hu K; Zhang X; Liu W; Yuan X; Jing H
J Transl Med; 2018 Dec; 16(1):363. PubMed ID: 30563570
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of CD45 expression by clonal bone marrow plasma cells in patients with newly diagnosed multiple myeloma.
Gonsalves WI; Timm MM; Rajkumar SV; Morice WG; Dispenzieri A; Buadi FK; Lacy MQ; Dingli D; Leung N; Kapoor P; Kyle RA; Gertz MA; Kumar SK
Leuk Res; 2016 May; 44():32-9. PubMed ID: 26994849
[TBL] [Abstract][Full Text] [Related]
26. E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271.
Natoni A; Smith TAG; Keane N; McEllistrim C; Connolly C; Jha A; Andrulis M; Ellert E; Raab MS; Glavey SV; Kirkham-McCarthy L; Kumar SK; Locatelli-Hoops SC; Oliva I; Fogler WE; Magnani JL; O'Dwyer ME
Leukemia; 2017 Dec; 31(12):2642-2651. PubMed ID: 28439107
[TBL] [Abstract][Full Text] [Related]
27. Expression of CRBN, IKZF1, and IKZF3 does not predict lenalidomide sensitivity and mutations in the cereblon pathway are infrequent in multiple myeloma.
Dimopoulos K; Fibiger Munch-Petersen H; Winther Eskelund C; Dissing Sjö L; Ralfkiaer E; Gimsing P; Grønbaek K
Leuk Lymphoma; 2019 Jan; 60(1):180-188. PubMed ID: 29718735
[TBL] [Abstract][Full Text] [Related]
28. Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells.
Bruns I; Cadeddu RP; Brueckmann I; Fröbel J; Geyh S; Büst S; Fischer JC; Roels F; Wilk CM; Schildberg FA; Hünerlitürkoglu AN; Zilkens C; Jäger M; Steidl U; Zohren F; Fenk R; Kobbe G; Brors B; Czibere A; Schroeder T; Trumpp A; Haas R
Blood; 2012 Sep; 120(13):2620-30. PubMed ID: 22517906
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche.
Tsukamoto S; Løvendorf MB; Park J; Salem KZ; Reagan MR; Manier S; Zavidij O; Rahmat M; Huynh D; Takagi S; Kawano Y; Kokubun K; Thrue CA; Nagano K; Petri A; Roccaro AM; Capelletti M; Baron R; Kauppinen S; Ghobrial IM
Leukemia; 2018 Aug; 32(8):1739-1750. PubMed ID: 29925904
[TBL] [Abstract][Full Text] [Related]
30. The RNA binding protein neuro-oncological ventral antigen 1 (NOVA1) regulates IL-6 mRNA stability to enhance JAK2-STAT3 signaling in CRC.
Hong YG; Xu GS; Yu GY; Zhou JD; Liu QZ; Ni JS; Yan HL; Zhang W; Hao LQ
Surg Oncol; 2019 Dec; 31():67-74. PubMed ID: 31541909
[TBL] [Abstract][Full Text] [Related]
31. Migration, adhesion and differentiation of malignant plasma cells in the 5T murine model of myeloma.
Asosingh K
Verh K Acad Geneeskd Belg; 2003; 65(2):127-34. PubMed ID: 12870183
[TBL] [Abstract][Full Text] [Related]
32. Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma.
Li Y; Zheng Y; Li T; Wang Q; Qian J; Lu Y; Zhang M; Bi E; Yang M; Reu F; Yi Q; Cai Z
Oncotarget; 2015 Sep; 6(27):24218-29. PubMed ID: 26155942
[TBL] [Abstract][Full Text] [Related]
33. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
[TBL] [Abstract][Full Text] [Related]
34. DNA Barcoding Reveals Habitual Clonal Dominance of Myeloma Plasma Cells in the Bone Marrow Microenvironment.
Hewett DR; Vandyke K; Lawrence DM; Friend N; Noll JE; Geoghegan JM; Croucher PI; Zannettino ACW
Neoplasia; 2017 Dec; 19(12):972-981. PubMed ID: 29091798
[TBL] [Abstract][Full Text] [Related]
35. Myeloma progenitors in the blood of patients with aggressive or minimal disease: engraftment and self-renewal of primary human myeloma in the bone marrow of NOD SCID mice.
Pilarski LM; Hipperson G; Seeberger K; Pruski E; Coupland RW; Belch AR
Blood; 2000 Feb; 95(3):1056-65. PubMed ID: 10648422
[TBL] [Abstract][Full Text] [Related]
36. RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.
Li M; Li AQ; Zhou SL; Lv H; Wei P; Yang WT
J Exp Clin Cancer Res; 2020 May; 39(1):92. PubMed ID: 32448269
[TBL] [Abstract][Full Text] [Related]
37. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
[TBL] [Abstract][Full Text] [Related]
38. JunB is a key regulator of multiple myeloma bone marrow angiogenesis.
Fan F; Malvestiti S; Vallet S; Lind J; Garcia-Manteiga JM; Morelli E; Jiang Q; Seckinger A; Hose D; Goldschmidt H; Stadlbauer A; Sun C; Mei H; Pecherstorfer M; Bakiri L; Wagner EF; Tonon G; Sattler M; Hu Y; Tassone P; Jaeger D; Podar K
Leukemia; 2021 Dec; 35(12):3509-3525. PubMed ID: 34007044
[TBL] [Abstract][Full Text] [Related]
39. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3.
Lin L; Cao L; Liu Y; Wang K; Zhang X; Qin X; Zhao D; Hao J; Chang Y; Huang X; Liu B; Zhang J; Lu J; Ge Q
Leukemia; 2019 Jun; 33(6):1475-1486. PubMed ID: 30573782
[TBL] [Abstract][Full Text] [Related]
40. Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming.
Liang Y; He H; Wang W; Wang H; Mo S; Fu R; Liu X; Song Q; Xia Z; Wang L
Mol Cancer; 2022 Sep; 21(1):182. PubMed ID: 36131282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
